130 related articles for article (PubMed ID: 25776440)
21. Impact of 24 months of anti-TNF therapy versus methotrexate on body weight in patients with rheumatoid arthritis: a prospective observational study.
Sfriso P; Caso F; Filardo GS; Botsios C; Costa L; Scarpa R; Todesco S; Spinella P; Oliviero F; Punzi L
Clin Rheumatol; 2016 Jun; 35(6):1615-8. PubMed ID: 27048267
[TBL] [Abstract][Full Text] [Related]
22. A prospective, longitudinal monocentric study on laser Doppler imaging of microcirculation: comparison with macrovascular pathophysiology and effect of adalimumab treatment in early rheumatoid arthritis.
Dávida L; Pongrácz V; Mohamed EA; Szamosi S; Szücs G; Váncsa A; Tímár O; Csiki Z; Végh E; Soltész P; Szekanecz Z; Kerekes G
Rheumatol Int; 2020 Mar; 40(3):415-424. PubMed ID: 31858209
[TBL] [Abstract][Full Text] [Related]
23. Pathway analysis to identify genetic variants associated with efficacy of adalimumab in rheumatoid arthritis.
Eektimmerman F; Swen JJ; Böhringer S; Huizinga TW; Kooloos WM; Allaart CF; Guchelaar HJ
Pharmacogenomics; 2017 Jul; 18(10):945-953. PubMed ID: 28639493
[TBL] [Abstract][Full Text] [Related]
24. The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylation.
Lin YC; Lin YC; Wu CC; Huang MY; Tsai WC; Hung CH; Kuo PL
Oncotarget; 2017 Jan; 8(5):7559-7571. PubMed ID: 27926504
[TBL] [Abstract][Full Text] [Related]
25. Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registry.
Ørnbjerg LM; Østergaard M; Bøyesen P; Krogh NS; Thormann A; Tarp U; Poulsen UE; Espesen J; Schlemmer A; Graudal N; Kollerup G; Jensen DV; Madsen OR; Glintborg B; Christensen T; Lindegaard H; Bøhme W; Hansen A; Andersen AR; Hetland ML
J Rheumatol; 2014 Dec; 41(12):2352-60. PubMed ID: 25274894
[TBL] [Abstract][Full Text] [Related]
26. Direct Comparative Effectiveness Among 3 Anti-Tumor Necrosis Factor Biologics in a Real-Life Cohort of Patients With Rheumatoid Arthritis.
Santos-Moreno P; Sánchez G; Gómez D; Bello-Gualtero J; Castro C
J Clin Rheumatol; 2016 Mar; 22(2):57-62. PubMed ID: 26886438
[TBL] [Abstract][Full Text] [Related]
27. Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1 year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measure.
Møller Døhn U; Boonen A; Hetland ML; Hansen MS; Knudsen LS; Hansen A; Madsen OR; Hasselquist M; Møller JM; Østergaard M
Ann Rheum Dis; 2009 Oct; 68(10):1585-90. PubMed ID: 19019887
[TBL] [Abstract][Full Text] [Related]
28. Persistence and dose escalation of tumor necrosis factor inhibitors in US veterans with rheumatoid arthritis.
Cannon GW; DuVall SL; Haroldsen CL; Caplan L; Curtis JR; Michaud K; Mikuls TR; Reimold A; Collier DH; Harrison DJ; Joseph GJ; Sauer BC
J Rheumatol; 2014 Oct; 41(10):1935-43. PubMed ID: 25128516
[TBL] [Abstract][Full Text] [Related]
29. Ex vivo inhibited cytokine profiling may explain inferior treatment response to golimumab after adalimumab failure in rheumatoid arthritis.
Tweehuysen L; Schraa K; Netea MG; van den Hoogen FHJ; Joosten LAB; den Broeder AA
Clin Exp Rheumatol; 2018; 36(1):140-143. PubMed ID: 29148425
[TBL] [Abstract][Full Text] [Related]
30. Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab.
Filippucci E; Iagnocco A; Salaffi F; Cerioni A; Valesini G; Grassi W
Ann Rheum Dis; 2006 Nov; 65(11):1433-7. PubMed ID: 16504996
[TBL] [Abstract][Full Text] [Related]
31. Predictive value of ultrasonographic assessment of disease activity in response to tumor necrosis factor-α inhibitor treatment in rheumatoid arthritis: a prospective cohort study.
Inanc N; Ozen G; Direskeneli H
Clin Exp Rheumatol; 2016; 34(1):156. PubMed ID: 26575409
[No Abstract] [Full Text] [Related]
32. EFFECT OF THERAPY WITH ANTI-TNF α DRUGS AND DMARD ON DISEASE ACTIVITY AND HEALTH RELATED QUALITY OF LIFE AMONG WOMEN WITH RHEUMATOID ARTHRITIS.
Kopciuch D; Paczkowska A; Leszczynsk P; Michalak M; Nowakowskai E
Acta Pol Pharm; 2016; 73(2):547-54. PubMed ID: 27180448
[TBL] [Abstract][Full Text] [Related]
33. Effect of serum anti-tumour necrosis factor (TNF) drug trough concentrations and antidrug antibodies (ADAb) to further anti-TNF short-term effectiveness after switching in rheumatoid arthritis and axial spondyloarthritis.
Vincent FB; Pavy S; Krzysiek R; Lequerré T; Sellam J; Taoufik Y; Mariette X; Miceli-Richard C
Joint Bone Spine; 2016 Oct; 83(5):595-7. PubMed ID: 27066773
[No Abstract] [Full Text] [Related]
34. VARIAR Study: Assessment of short-term efficacy and safety of rituximab compared to an tumor necrosis factor alpha antagonists as second-line drug therapy in patients with rheumatoid arthritis refractory to a first tumor necrosis factor alpha antagonist.
Torrente-Segarra V; Acosta Pereira A; Morla R; Ruiz JM; Clavaguera T; Figuls R; Corominas H; Geli C; Roselló R; de Agustín JJ; Alegre C; Pérez C; García A; Rodríguez de la Serna A
Reumatol Clin; 2016; 12(6):319-322. PubMed ID: 26831256
[TBL] [Abstract][Full Text] [Related]
35. Retention rates of adalimumab, etanercept and infliximab as first-line biotherapy agent for rheumatoid arthritis patients in daily practice - Auvergne experience.
Soubrier M; Pereira B; Frayssac T; Fan A; Couderc M; Malochet-Guinamand S; Mathieu S; Tatar Z; Tournadre A; Dubost JJ
Int J Rheum Dis; 2018 Nov; 21(11):1924-1932. PubMed ID: 28901727
[TBL] [Abstract][Full Text] [Related]
36. Development of type 1 diabetes mellitus in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor alpha.
Richez C; Blanco P; Gin H; Schaeverbeke T
Clin Exp Rheumatol; 2006; 24(5):607. PubMed ID: 17181936
[No Abstract] [Full Text] [Related]
37. Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial.
Burmester GR; Mariette X; Montecucco C; Monteagudo-Sáez I; Malaise M; Tzioufas AG; Bijlsma JW; Unnebrink K; Kary S; Kupper H
Ann Rheum Dis; 2007 Jun; 66(6):732-9. PubMed ID: 17329305
[TBL] [Abstract][Full Text] [Related]
38. Effect of the TNF-α inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET.
Milman N; Graudal N; Loft A; Mortensen J; Larsen J; Baslund B
Clin Respir J; 2012 Oct; 6(4):238-47. PubMed ID: 22128762
[TBL] [Abstract][Full Text] [Related]
39. Which TNF inhibitor for rheumatoid arthritis?
Med Lett Drugs Ther; 2010 May; 52(1338):38-9. PubMed ID: 20467356
[No Abstract] [Full Text] [Related]
40. Serious infections under treatment with TNF-alpha antagonists compared to traditional DMARDs in patients with rheumatoid arthritis.
Inanc N; Direskeneli H
Rheumatol Int; 2006 Nov; 27(1):67-71. PubMed ID: 16896990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
